Steven A Johnson Selected Research

1-(quinoxalin-6-ylcarbonyl)piperidine (CX516)

2/2008	A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.
10/2006	Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial.
8/2002	Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven A Johnson Research Topics

Disease

2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2022 - 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 12/2010
1	Renal Insufficiency (Renal Failure) 12/2010
1	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2008
1	Fatigue 02/2008
1	Schizophrenia (Dementia Praecox) 02/2008
1	Fragile X Syndrome (Martin Bell Syndrome) 10/2006
1	Exanthema (Rash) 10/2006
1	Cognitive Dysfunction 08/2002
1	Memory Disorders (Memory Loss) 08/2002

Drug/Important Bio-Agent (IBA)

3	1-(quinoxalin-6-ylcarbonyl)piperidine (CX516)IBA 02/2008 - 08/2002
2	Lisdexamfetamine Dimesylate FDA Link 12/2022 - 01/2022
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 10/2006 - 08/2002
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2010
1	Olanzapine (Zyprexa)FDA Link 02/2008
1	Clozapine (Clozaril)FDA LinkGeneric 02/2008
1	Risperidone (Risperdal Consta)FDA LinkGeneric 02/2008
1	Glutamate Receptors (Glutamate Receptor)IBA 08/2002

Therapy/Procedure

1	Mechanical Ventilators (Ventilator) 12/2010